Feb 26, 2019 - Top drug companies addressed sky-high drug prices on Capitol Hill today.
Feb 27, 2019 - Chardan Capital Markets reiterates its Buy rating on gene therapy developer MeiraGTx (MGTX +14.4%) with a more bullish price target of $40 (165% upside) (from $30) after it announced a stake by a grou
Feb 28, 2019 - These three titans of their respective industries should be able to weather nearly any market environment.
Mar 03, 2019 - These biopharmaceutical startups have been losing their investors' money for decades.
Mar 04, 2019 - The Zacks Analyst Blog Highlights: Facebook, Johnson & Johnson, JPMorgan, Sun Life and Evergy
Mar 06, 2019 - Here is what investors need to know about smart beta and factor strategies that combine the best aspects of active and passive investing.
Mar 08, 2019 - Here is what investors need to know about smart beta and factor strategies that combine the best aspects of active and passive investing.
Mar 14, 2019 - Johnson & Johnson (NYSE:JNJ) Barclays Global Healthcare Conference Call March 14, 2019, 10:15 ET Company Participants Lesley Fishman - IR Chris DelOrefice - VP, IR Catherine Owen - President, Immu
Mar 15, 2019 - Regulatory updates from J&J (JNJ), Merck (MRK), Roche (RHHBY), Pfizer (PFE) and others.
Mar 15, 2019 - Companies In The News Are:
BA, DG, JNJ, WAGE